Medpace Holdings Inc vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? Medpace Holdings Inc trades at $611.57 (market cap $16.82B), while Direxion Daily Semiconductor Bear 3X Shares trades at $34.44 (market cap $1.96B). The key difference: Medpace Holdings Inc is far larger — about 8.6× Direxion Daily Semiconductor Bear 3X Shares's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Direxion Daily Semiconductor Bear 3X Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and Direxion Daily Semiconductor Bear 3X Shares for 11 Days on average.
| MEDP | SOXS | |
|---|---|---|
Market Cap | $16.82B | $1.96B |
Volume | 223,093 | 113,512,541 |
Sector | Health | Leveraged / Inverse |
52-Week High | $630.19 | $988.00 |
52-Week Low | $393.42 | $29.62 |
Typical Hold Time | 14 Days | 11 Days |
Enterprise Value | $16.44B | — |
Signals from Pluang's Aura AI — not financial advice
Medpace (MEDP) trades at $617.47, up 2.19% with strong quarterly earnings beats and robust profitability metrics. The stock shows neutral technical signals with key resistance at $620, while fundamentals reveal impressive ROE of 162.15% and consistent revenue growth to $2.8B projected for 2026. Recent CEO stock sales and mixed institutional activity create balanced sentiment ahead of Q3 earnings announcement on October 21, 2026.
MEDP presents growth potential with analyst consensus target of $620.44 and strong historical execution, though elevated valuations (P/E 35.41) and insider selling warrant caution. The stock's upside depends on continued earnings delivery amid competitive medical services landscape.
SOXS, the Direxion Daily Semiconductor Bear 3X ETF, trades at $34.53, up 12.68% with a bearish technical signal. The fund provides inverse leveraged exposure to semiconductor stocks, making it highly volatile and suitable for short-term tactical trades rather than long-term investment. Recent performance reflects semiconductor sector weakness, with technical indicators showing mixed signals but overall bearish momentum.
The outlook remains challenging as SOXS faces structural headwinds from persistent AI hardware demand and semiconductor industry strength. Investment opportunities exist for tactical bearish bets during sector pullbacks, but risks include high volatility, decay from daily rebalancing, and potential for rapid losses if semiconductor stocks rebound. The fund is best suited for experienced traders with short-term horizons.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →